Universe · entity
Ally Bridge Group (NY) LLC
Institutional manager (13F) · CIK 1822947
13F holdings · as of 2026-03-31 · top 21 · reported portfolio $101M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | $11M | 32,810 |
| 2 | MINERVA NEUROSCIENCES INC | $10M | 1,655,500 |
| 3 | SOLENO THERAPEUTICS INC | $7M | 200,000 |
| 4 | OVID THERAPEUTICS INC | $6M | 2,818,459 |
| 5 | COMPASS PATHWAYS PLC | $6M | 1,045,000 |
| 6 | TARSUS PHARMACEUTICALS INC | $6M | 80,859 |
| 7 | SOLID BIOSCIENCES INC | $6M | 766,974 |
| 8 | PROMIS NEUROSCIENCES INC | $5M | 414,219 |
| 9 | EDGEWISE THERAPEUTICS INC | $5M | 161,000 |
| 10 | EUPRAXIA PHARMACEUTICALS INC | $5M | 660,375 |
| 11 | CYTOMX THERAPEUTICS INC. | $4M | 900,000 |
| 12 | INVENTIVA SA | $4M | 745,300 |
| 13 | PERSPECTIVE THERAPEUTICS INC | $4M | 926,557 |
| 14 | ABIVAX SA | $4M | 33,712 |
| 15 | ALUMIS INC | $4M | 166,959 |
| 16 | UROGEN PHARMA LTD | $4M | 202,124 |
| 17 | CAPRICOR THERAPEUTICS INC | $3M | 113,899 |
| 18 | WHITEHAWK THERAPEUTICS INC | $3M | 817,939 |
| 19 | INHIBIKASE THERAPEUTICS INC | $2M | 1,325,000 |
| 20 | AN2 THERAPEUTICS INC | $2M | 526,315 |
| 21 | RELMADA THERAPEUTICS INC | $1M | 210,525 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.